AR

Alex Rosen

Biotech Investor at Spruce Street Capital

New York, New York

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $3,000,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $6,500,000.00

Skills

Data Analysis
Clinical Research
Research
Statistics
Biotechnology
Strategy
Public Health
Lifesciences
Science
Program Evaluation
Molecular Biology
Life Sciences
Healthcare
Business Development
Leadership
Qualitative Research
Stata

Education

Lists including Alex

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

TG
AM
DL
DA

Investors interested in search

58 people

Work Experience

SS
Spruce Street Capital LP

2024

  • Managing Partner

    2024

UB
Upstream Bio

2023 - 2023

  • Board Member

    2023 - 2023

V
Venrock

2016 - 2023

  • Partner

    2020 - 2023

  • Biotech investor

    2016 - 2023

    Public and private/crossover biotechnology investing

R
RayzeBio

2022 - 2023

  • Board Member

    2022 - 2023

    IPO Sep 2023 (NASDAQ: RYZB) acquired by Bristol Myers Squibb for $4.1 billion, Dec 2023

RP
Regeneron Pharmaceuticals, Inc.

2015 - 2015

  • Business Development

    2015 - 2015

M&
McKinsey & Company

2014 - 2014

  • Summer Associate

    2014 - 2014

Latest Articles

Medium•May 2022

Top 10 Listicle

Com 250
Listicles
online news consumption
credibility and authenticity
search engines